Mounjaro API: What the Active Ingredient Tirzepatide Is (October 2026)

01 · The core answer

What the Mounjaro API means for you as a patient

The API in Mounjaro is tirzepatide, and for a patient that single fact answers most practical questions. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.¹ If a leaflet, a prescription or a pharmacy label says tirzepatide, it is talking about the same active ingredient that is in the Mounjaro pen.

The term API comes from manufacturing. It means the part of a medicine that produces the therapeutic effect, as opposed to the other ingredients that keep the product stable or make it injectable. Tirzepatide is the API; the full list of other ingredients is printed in the patient information leaflet that comes with every pen.¹³

Why does the distinction matter? Because "tirzepatide API" is also a phrase used in industrial and research supply chains, where the raw substance is traded in bulk for manufacturing. That is not a product a member of the public can safely use. A patient needs the finished, licensed medicine: the correct dose, in a sterile, pre-filled pen, labelled and dispensed after a clinical review.

02 · Next steps

The decisions most readers are actually facing

Most people reading about the API are weighing up one of three things: whether Mounjaro is relevant to them, whether to wait for the NHS or go private, and how to be sure what they receive is genuine. Each has a straightforward route.

On relevance: Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity, and individual results vary.¹ Whether it suits you is a prescriber decision, not something a web page can settle.

On NHS versus private: Mounjaro is available on the NHS, but access is being phased in over several years, with the highest-need groups first.⁴ Many people who meet the licensed criteria choose regulated private treatment rather than wait. If you go private, the product you receive should be the same licensed tirzepatide pen.

On authenticity: we supply Mounjaro through official LillyDirect supply, sourced directly from Eli Lilly's UK distribution, as genuine KwikPens in every strength from 2.5mg to 15mg. Our pharmacy is registered with the GPhC under number 9012878, and you can check the register yourself.¹²

If you are ready to look at the next step, the Mounjaro pen, prices and consultation page shows live prices and starts the free consultation. A first 2.5mg pen costs £129.99 as a first-order price with code FIRST40 (standard price £169.99). For the wider picture of how we support weight management, see our weight loss clinic. The consultation is free and the price shown is the price paid.

Related guides: Mounjaro formulary and Mounjaro contraindicaciones.

Related guide: Tirzepatide api price.

03 · Ingredient versus brand

Tirzepatide versus Mounjaro: ingredient versus brand

Tirzepatide is the ingredient and Mounjaro is the product. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

That wording matters because the market is full of look-alike phrases. You may see "tirzepatide", "tirzepatide injection", "Mounjaro" and "tirzepatide API" used almost interchangeably. They are not interchangeable. The API is the raw active substance. Mounjaro is the finished, licensed medicine that contains it, produced to pharmaceutical standards, presented in a device designed for self-injection, and accompanied by an approved summary of product characteristics and patient leaflet.¹¹³

The same logic applies to medicines more generally. A tablet of paracetamol is not simply paracetamol powder; it is a formulated, tested and labelled product. With an injectable the stakes are higher, because the contents go under the skin. Sterility, accurate dosing and traceable supply are what you are paying for when you buy a licensed pen, and none of them come with a bulk ingredient.

Is there anything in a Mounjaro pen other than tirzepatide that you should worry about? The patient information leaflet lists every other ingredient, and it is the right place to check if you have a known allergy.¹³ If you are unsure, raise it during your consultation so the prescriber can review it with you.

You may also notice that some writing about the API refers to a pen "cartridge". The licensed UK product is the KwikPen. If you want to understand how the device itself is described, our guide to the Mounjaro cartridge question explains the terminology and what the pen contains.

In short: the API tells you what the medicine is made of; the brand and licence tell you that someone has tested, approved and is accountable for the finished product. When you are choosing where to get treatment, accountability is the thing to look for.

04 · How tirzepatide works

How the active ingredient works in the body

Tirzepatide works by activating natural gut-hormone receptors, and it is unusual in doing so at two sites. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

What does that feel like in daily life? In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ The medicine does not replace eating well or moving more. It makes a reduced-calorie diet easier to follow for many people, which is why it is prescribed alongside lifestyle changes rather than instead of them.

The dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ That is a statement about mechanism only. It is not, on its own, a claim that one will suit you better than the other; the prescriber looks at your history, your goals and your tolerance. Our page on Mounjaro pharmacodynamics goes into more depth on how the medicine acts on the body.

Slower stomach emptying is worth understanding because it explains both a benefit and a limitation. It is part of why you feel full for longer. It is also why the medicine can interact with how other oral medicines are absorbed, which is the reason contraception advice is part of every prescriber conversation.

Why a weekly injection? Tirzepatide stays active in the body for a long time, which is what allows a single weekly dose.

A caution about shortcuts. You will find websites that describe the receptor biology in great detail and then suggest that the raw ingredient can be reconstituted or combined at home. Understanding a mechanism does not make that safe. The licensed pen is built to deliver a defined dose, and any dosing outside the licence is not something we can support. If you are curious about the science, read it; if you want treatment, use the licensed route.

05 · Strengths and the KwikPen

Strengths, the KwikPen and how the dose is built up

The licensed API reaches you as a KwikPen, and the strength you receive is chosen by your prescriber. Mounjaro comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ Our pharmacy stocks all of them, and every dose is in stock.

Treatment begins at the lowest strength and the dose is stepped up gradually under prescriber review. If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices, before any discount; a new customer's first order is £40 less and every later order is £25 less. Your prescriber decides the pace, with at least 4 weeks on each dose, depending on how you respond.

Where do you settle? Some people stay at a lower strength; others move to a higher one. That is decided at your regular reviews, which are included with our service, and it depends on response and side effects rather than on a target number. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg, at standard prices before discounts. For other maintenance doses, look at the monthly price for that strength: £279.99 at 7.5mg, £290.99 at 10mg and £319.99 at 12.5mg.

Once a pen is in use, it can be kept out of the fridge at a temperature not above 30°C for up to 30 days, and must then be thrown away. Unopened pens are stored in the fridge until first use and keep until the printed expiry date. For anything beyond that, the patient information leaflet and your pharmacy are the right sources.¹³

Needles, a sharps bin and injection guidance are included with every order, so you do not need to buy anything separately to get started.

06 · What the trial evidence shows

What the evidence shows for tirzepatide

SURMOUNT-1 is the main trial for tirzepatide in weight management. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages, and they do not predict your own result. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² Some people lose more than the average and some lose less, which is why a prescriber reviews progress rather than promising an outcome.

The same trial reported how many participants reached particular milestones. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

To make a percentage tangible, use a worked example. For someone starting at 100 kg, 20.9% is about 21 kg. That is straight arithmetic on the trial average, not a forecast for any one person, and it says nothing about how long it takes you to get there.

How should you read these numbers? First, they apply to people taking the licensed medicine in a supervised trial setting alongside lifestyle support. They do not apply to a raw ingredient or an unlicensed product, because nobody has measured what those do. Second, a trial average is a description of a group.

What about comparisons with other medicines? Different trials enrol different people and are run in different ways, so placing their numbers side by side proves little. If you are weighing semaglutide against tirzepatide, ask your prescriber to talk it through rather than relying on headline figures from separate studies.

07 · NHS and private access

Who can get tirzepatide, on the NHS and privately

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

What is the minimum BMI for Mounjaro? For NHS access, the NICE recommendation starts at a BMI of 35 with a weight-related condition, and the first wave of the rollout is narrower than that. For private treatment, the prescriber assesses your suitability against the licence and your health history during the consultation.

What is the "new rule" for Mounjaro that people ask about? What has genuinely changed is the phased NHS rollout, and the NHS guidance pages are the right place to check the current position.⁵ If you read a headline about a new rule, check it against the NICE and NHS England pages rather than a third-party summary.

On the private route, the journey is simple and transparent. You complete a free online consultation, a short health questionnaire with no charge and no obligation. A GPhC-registered prescriber reviews it, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Approved orders are dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm and free next-day tracked delivery in discreet, temperature-controlled packaging.

Ongoing care is part of the service. Monthly reviews, dose titration, follow-up assessments and side-effect support come from the prescribing team, and repeat orders re-check suitability, with no auto-shipping. There are no subscriptions, and Klarna and pay-monthly options are available.

If you qualify and are happy to wait, NHS treatment may suit you. If you want to start sooner and are comfortable paying, a regulated private pharmacy offers the same licensed medicine. What matters in both cases is that a clinician is overseeing it.

08 · Safety and genuine supply

Safety, interactions and spotting genuine supply

The safest source of tirzepatide is a licensed, dispensed pen. Our Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens. You can verify our registration, GPhC 9012878, on the public register.¹² A legitimate seller will always want a consultation and a prescription first.

Counterfeit and unlicensed products are a real risk in this area, and the MHRA publishes counterfeit medicine alerts.⁷ Warning signs include anyone offering to supply without a consultation or prescription, sellers who describe the product only as a powder or "research" material, and dramatic weight-loss claims. If a deal looks too easy, treat that as the warning.

Medicines that can interact deserve a mention. The medicine can reduce absorption of oral contraceptives, because stomach emptying slows, so contraception is something to discuss with your prescriber.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If you take insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar; that is a conversation for your prescriber, not a reason to stop anything yourself.¹

What should you avoid while taking it? The most useful answer is to tell your prescriber about every medicine and supplement you use, and to avoid anything that is not part of the licensed treatment, including unregulated products sold as copies. Mounjaro should not be taken if you are allergic to tirzepatide or any of its ingredients, or during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation.

Side effects can occur. For any new or lasting symptom, tell your prescriber, and report suspected side effects through the MHRA Yellow Card scheme.¹⁹

Finally, a note on who the medicine is for. Mounjaro is a prescription-only medicine used alongside a reduced-calorie diet and increased physical activity, and individual results vary. This page is information, not a substitute for medical advice.

09 · Stopping and what happens next

Stopping tirzepatide: clearance and what to expect

Stopping is a decision to make with your prescriber, and the first thing to know is how long the ingredient stays in your body. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹

That long clearance has practical consequences. Effects on appetite do not vanish the moment you miss a dose, and they fade gradually rather than suddenly. If you are thinking about stopping because of side effects, speak to your prescriber first.

When should you stop? There is no single date. Reasons people stop include reaching a goal, side effects they cannot tolerate, a change in health, or cost. If you become pregnant, stop the medicine and tell your prescriber promptly; Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. Each of those deserves a conversation, and our ongoing monthly reviews exist for exactly this.

Do people regain weight afterwards? In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load. Ask your prescriber to help you plan that transition before you reach it, not after.

Our support team is available Monday to Friday, 9am to 5pm, on 0333 207 0413 or at support@everydaymeds.co.uk. The free GLPTrackr app can also help you keep a record to bring to reviews.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹